{"nct_id":"NCT03242889","title":"A Study of Subcutaneous Delivery of JNJ-54767414 (Daratumumab) in Japanese Participants With Relapsed or Refractory Multiple Myeloma","status":"COMPLETED","status_verified_date":"2023-04","start_date":"2017-08-10","start_date_type":"ACTUAL","primary_completion_date":"2017-11-01","primary_completion_date_type":"ACTUAL","completion_date":"2023-02-10","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["JNJ"]}